1) Alexander GE, DeLong MR, Strick PL:Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381, 1986
2) Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP:Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62:554-560, 2005
3) Andrade P, Carrillo-Ruiz JD, Jiménez F:A systematic review of the efficacy of globus pallidus stimulation in the treatment of Parkinson's disease. J Clin Neurosci 16:877-881, 2009
4) Antonini A, Isaias IU, Rodolfi G, Landi A, Natuzzi F, Siri C, Pezzoli G:A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol 258:579-585, 2011
5) Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, Laurent A, Gentil M, Perret J:Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 62:76-84,1994
6) Burchiel KJ, Anderson VC, Favre J, Hammerstad JP:Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease:results of a randomized, blinded pilot study. Neurosurgery 45:1375-1382, 1999
7) Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E:Ten-year outcome of subthalamic stimulation in Parkinson disease:a blinded evaluation. Arch Neurol 68:1550-1556, 2011
8) Combs HL, Folley BS, Berry DT, Segerstrom SC, Han DY, Anderson-Mooney AJ, Walls BD, van Horne C:Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson's disease:a meta-analysis. Neuropsychol Rev 25:439-454, 2015
9) Couto MI, Monteiro A, Oliveira A, Lunet N, Massano J:Depression and anxiety following deep brain stimulation in Parkinson's disease:systematic review and meta-analysis. Acta Med Port 27:372-382, 2014
10) Deep-Brain Stimulation for Parkinson's Disease Study Group, Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE:Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 345:956-963, 2001
11) DeLong MR:Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285, 1990
12) Derrey S, Chastan N, Maltete D, Verin E, Dechelotte P, Lefaucheur R, Proust F, Freger P, Leroi AM, Weber J, Gourcerol G:Impact of deep brain stimulation on pharyngo-esophageal motility:a randomized cross-over study. Neurogastroenterol Motil 27:1214-1222, 2015
13) Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J;German Parkinson Study Group, Neurostimulation Section:A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355:896-908, 2006
14) Dietz J, Noecker AM, McIntyre CC, Mikos A, Bowers D, Foote KD, Okun MS:Stimulation region within the globus pallidus does not affect verbal fluency performance. Brain Stimul 6:248-253, 2013
15) Espay AJ, Vaughan JE, Marras C, Fowler R, Eckman MH:Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease:a decision analysis. Mov Disord 25:1456-1463, 2010
16) Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ;CSP 468 Study Group:Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 362:2077-2091, 2010
17) Gee L, Smith H, De La Cruz P, Campbell J, Fama C, Haller J, Ramirez-Zamora A, Durphy J, Hanspal E, Molho E, Barba A, Shin D, Pilitsis JG:The influence of bilateral subthalamic nucleus deep brain stimulation on impulsivity and prepulse inhibition in Parkinson's disease patients. Stereotact Funct Neurosurg 93:265-270, 2015
18) Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro H, Tagliati M, Koller WC, Olanow CW:Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 16:493-497, 2009
19) Hariz MI, Krack P, Melvill R, Jorgensen JV, Hamel W, Hirabayashi H, Lenders M, Wesslen N, Tengvar M, Yousry TA:A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 80:96-101, 2003
20) Hirabayashi H, Tengvar M, Hariz MI:Stereotactic imaging of the pallidal target. Mov Disord 17(Suppl 3):S130-S134, 2002
21) Højlund A, Petersen MV, Sridharan KS, Østergaard K:Worsening of verbal fluency after deep brain stimulation in Parkinson's disease:a focused review. Comput Struct Biotechnol J 15:68-74, 2016
22) Katz M, Luciano MS, Carlson K, Luo P, Marks WJ Jr, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL;CSP 468 study group:Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Ann Neurol 77:710-719, 2015
23) Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ:Relationships between age and late progression of Parkinson's disease:a clinico-pathological study. Brain 133(Pt 6):1755-1762, 2010
24) Khoo HM, Kishima H, Hosomi K, Maruo T, Tani N, Oshino S, Shimokawa T, Yokoe M, Mochizuki H, Saitoh Y, Yoshimine T:Low-frequency subthalamic nucleus stimulation in Parkinson's disease:a randomized clinical trial. Mov Disord 29:270-274, 2014
25) Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G:Subthalamic nucleus deep brain stimulation:summary and meta-analysis of outcomes. Mov Disord 21(Suppl 14):S290-S304, 2006
26) Locke MC, Wu SS, Foote KD, Sassi M, Jacobson CE, Rodriguez RL, Fernandez HH, Okun MS:Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation:results from the COMPARE Parkinson disease deep brain stimulation cohort. Neurosurgery 68:1233-1237;discussion 1237-1238, 2011
27) Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE:Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 25:578-586, 2010
28) Nambu A, Tokuno H, Takada M:Functional significance of the cortico-subthalamo-pallidal ‘hyperdirect’ pathway. Neurosci Res 43:111-117, 2002
29) Nambu A:Globus pallidus internal segment. GABA and the Basal Ganglia:From Molecules to Systems. Prog Brain Res 160:135-150, 2007
30) Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, Beute GN, van Vugt JP, Lenders MW, Contarino MF, Mink MS, Bour LJ, van den Munckhof P, Schmand BA, de Haan RJ, Schuurman PR, de Bie RM:Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease(NSTAPS study):a randomised controlled trial. Lancet Neurol 12:37-44, 2013
31) Odekerken VJ, Boel JA, Schmand BA, de Haan RJ, Figee M, van den Munckhof P, Schuurman PR, de Bie RM;NSTAPS study group:GPi vs STN deep brain stimulation for Parkinson disease:three-year follow-up. Neurology 86:755-761, 2016
32) Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, Suelter M, Jacobson CE 4th, Wang X, Gordon CW Jr, Zeilman P, Romrell J, Martin P, Ward H, Rodriguez RL, Foote KD:Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation:the COMPARE trial. Ann Neurol 65:586-595, 2009
33) Okun MS, Wu SS, Fayad S, Ward H, Bowers D, Rosado C, Bowen L, Jacobson C, Butson C, Foote KD:Acute and chronic mood and apathy outcomes from a randomized study of unilateral STN and GPi DBS. PLoS One 9:e114140, 2014
34) Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, Fabre N, Lotterie JA, Chaynes P, Berry I, Lazorthes Y, Rascol O:Does ageing influence deep brain stimulation outcomes in Parkinson's disease? Mov Disord 22:1457-1463, 2007
35) 「パーキンソン病診療ガイドライン」作成委員会(編),日本神経学会(監):パーキンソン病診療ガイドライン2018.医学書院,東京,2018,pp.77-86
36) Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI:Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease:a meta-analysis. Lancet Neurol 5:578-588, 2006
37) Perestelo-Pérez L, Rivero-Santana A, Pérez-Ramos J, Serrano-Pérez P, Panetta J, Hilarion P:Deep brain stimulation in Parkinson's disease:meta-analysis of randomized controlled trials. J Neurol 261:2051-2060, 2014
38) Ricchi V, Zibetti M, Angrisano S, Merola A, Arduino N, Artusi CA, Rizzone M, Lopiano L, Lanotte M:Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients:a 15 months follow-up study. Brain Stimul 5:388-392, 2012
39) Rizzone MG, Fasano A, Daniele A, Zibetti M, Merola A, Rizzi L, Piano C, Piccininni C, Romito LM, Lopiano L, Albanese A:Long-term outcome of subthalamic nucleus DBS in Parkinson's disease:from the advanced phase towards the late stage of the disease? Parkinsonism Relat Disord 20:376-381, 2014
40) Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL:Globus pallidus stimulation in advanced Parkinson's disease. J Clin Neurosci 14:208-215, 2007
41) Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N:Bilateral deep brain stimulation in Parkinson's disease:a multicentre study with 4 years follow-up. Brain 128(Pt 10):2240-2249, 2005
42) Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D;CSP-468 Study Group:Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease:comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry 86:622-629, 2015
43) Rouaud T, Dondaine T, Drapier S, Haegelen C, Lallement F, Péron J, Raoul S, Sauleau P, Vérin M:Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation. Mov Disord 25:1839-1846, 2010
44) Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ:Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 63:1952-1954, 2004
45) Sako W, Miyazaki Y, Izumi Y, Kaji R:Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation. J Neurol Neurosurg Psychiatry 85:982-986, 2014
46) Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G;EARLYSTIM Study Group:Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 368:610-622, 2013
47) Schüpbach WM, Maltête D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Gargiulo M, Béhar C, Bonnet AM, Czernecki V, Pidoux B, Navarro S, Dormont D, Cornu P, Agid Y:Neurosurgery at an earlier stage of Parkinson disease:a randomized, controlled trial. Neurology 68:267-271, 2007
48) Sidiropoulos C, Walsh R, Meaney C, Poon YY, Fallis M, Moro E:Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease. J Neurol 260:2306-2311, 2013
49) Siegfried J, Lippitz B:Bilateral chronic electrostimulation of ventroposterolateral pallidum:a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35:1126-1129;discussion 1129-1130, 1994
50) Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, Delval A, Blond S, Defebvre L, Destée A, Krystkowiak P:Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease:a second honeymoon. J Neurol 256:1736-1741, 2009
51) Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B:Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease. J Neurol Neurosurg Psychiatry 82:754-760, 2011
52) Taba HA, Wu SS, Foote KD, Hass CJ, Fernandez HH, Malaty IA, Rodriguez RL, Dai Y, Zeilman PR, Jacobson CE, Okun MS:A closer look at unilateral versus bilateral deep brain stimulation:results of the National Institutes of Health COMPARE cohort. J Neurosurg 113:1224-1229, 2010
53) Taoka T, Hirabayashi H, Nakagawa H, Sakamoto M, Kitano S, Takahama J, Marugami N, Takayama K, Akashi T, Miyasaka T, Iwasaki S, Kurita N, Sakaki T, Kichikawa K:“Sukeroku sign” and “dent internal-capsule sign” --identification guide for targeting the subthalamic nucleus for placement of deep brain stimulation electrodes. Neuroradiology 51:11-16, 2009
54) Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V:Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease:a systematic review. Parkinsonism Relat Disord 12:265-272, 2006
55) Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY:Prognostic factors of subthalamic stimulation in Parkinson's disease:a comparative study between short- and long-term effects. Stereotact Funct Neurosurg 87:241-248, 2009
56) Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y:Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 24:1154-1161, 2009
57) Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schüpbach M, D'Ambrosia J, Thobois S, Tamma F, Herzog J, Speelman JD, Samanta J, Kubu C, Rossignol H, Poon YY, Saint-Cyr JA, Ardouin C, Moro E:A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131(Pt 10):2720-2728, 2008
58) Weaver F, Follett K, Hur K, Ippolito D, Stern M:Deep brain stimulation in Parkinson disease:a metaanalysis of patient outcomes. J Neurosurg 103:956-967, 2005
59) Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD;CSP 468 Study Group:Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease:a randomized controlled trial. JAMA 301:63-73, 2009
60) Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ;CSP 468 Study Group:Randomized trial of deep brain stimulation for Parkinson disease:thirty-six-month outcomes. Neurology 79:55-65, 2012
61) Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM;CSP 468 Study Group:Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease:results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry 84:1113-1118, 2013
62) Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, Scott R, Ives N, Rick C, Daniels J, Patel S, Wheatley K;PD SURG Collaborative Group:Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease(PD SURG trial):a randomised, open-label trial. Lancet Neurol 9:581-591, 2010
63) Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G:Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease:a randomised, multicentre study. Lancet Neurol 7:605-614, 2008
64) Wyman-Chick KA:Verbal fluency in Parkinson's patients with and without bilateral deep brain stimulation of the subthalamic nucleus:a meta-analysis. J Int Neuropsychol Soc 22:478-485, 2016
65) Xie T, Vigil J, MacCracken E, Gasparaitis A, Young J, Kang W, Bernard J, Warnke P, Kang UJ:Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology 84:415-420, 2015
66) Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Wu SS, Kirsch-Darrow L, Jacobson CE 4th, Rosado C, Bowers D:Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol 256:1321-1329, 2009